Impact of Empagliflozin Versus Dapagliflozin on Left Ventricular Remodeling in Heart Failure Patients: A 1‐Year Comparative Study

Documenti analoghi

• Cerebral Embolic Protection Devices (CEPDs) During Transcatheter Aortic Valve Implantation (TAVI): A Meta‐Analysis of Randomized Controlled Trials
  di: Mohamed Ibrahim Gbreel, et al.
  Pubblicazione: (2026)
• Effects of Dapagliflozin on Novel Inflammatory Markers in Heart Failure Patients
  di: Oktay Senoz, et al.
  Pubblicazione: (2026)
• Safety and Efficiency of Cephalic Vein Puncture by Modified Seldinger Technique Compared to Subclavian Vein Puncture for Cardiac Implantable Electronic Devices
  di: Marie‐Christine Weidauer, et al.
  Pubblicazione: (2024)
• Relationship Between Left Ventricular Ejection Fraction and ICD‐10 Codes Among Patients Hospitalized With Heart Failure
  di: Ty J. Gluckman, et al.
  Pubblicazione: (2024)
• Letter Regarding “Outcomes of Bolus Dose Furosemide Versus Continuous Infusion in Patients With Acute Decompensated Left Ventricular Failure and Atrial Fibrillation”
  di: Ahmed M. Gazer, et al.
  Pubblicazione: (2024)